Descriptor English: | Brentuximab Vedotin | ||||
Descriptor Spanish: |
Brentuximab Vedotina
| ||||
Descriptor Portuguese: | Brentuximab Vedotin | ||||
Descriptor French: | Brentuximab védotine | ||||
Entry term(s): |
Adcetris CAC10 1006 CAC10-1006 CAC101006 SGN 35 SGN-35 SGN35 cAC10 vcMMAE cAC10-vcMMAE cAC10vcMMAE |
||||
Tree number(s): |
D12.644.456.217 D12.776.124.486.485.114.224.060.438 D12.776.124.790.651.114.224.060.469 D12.776.377.715.548.114.224.200.469 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000079963 | ||||
Scope note: | Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Antineoplastic Agents, Immunological Immunotoxins |
||||
Registry Number: | 7XL5ISS668 | ||||
Public MeSH Note: | 2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019 |
||||
History Note: | 2020 (2010) |
||||
DeCS ID: | 59042 | ||||
Unique ID: | D000079963 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2020/01/01 | ||||
Date of Entry: | 2019/07/08 | ||||
Revision Date: | 2019/01/15 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Brentuximab Vedotin
- Preferred
cAC10-vcMMAE
- Narrower
Adcetris
- Narrower
CAC10-1006
- Narrower
SGN-35
- Narrower
Concept UI |
M0551563 |
Scope note | Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA. |
Preferred term | Brentuximab Vedotin |
Concept UI |
M000646126 |
Preferred term | cAC10-vcMMAE |
Entry term(s) |
cAC10 vcMMAE cAC10vcMMAE |
Concept UI |
M0561630 |
Preferred term | Adcetris |
Concept UI |
M000646125 |
Preferred term | CAC10-1006 |
Entry term(s) |
CAC10 1006 CAC101006 |
Concept UI |
M0544351 |
Preferred term | SGN-35 |
Entry term(s) |
SGN 35 SGN35 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey